Source: Siyu MedTech; Editor: Zhang YuqingReprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.
Recently,New Cloud Medical Completes Tens of Millions of Yuan in Series B Financing.The funds from this round of financing will be used to advance the clinical trials and registration approval of the company's domestically pioneering products, such as the NewMild minimally invasive surgical instrument suite for lumbar spinal stenosis and the closed-loop rechargeable spinal cord stimulation system, continuously expand the research and development team, and enhance the company’s pain management device product line.
Chronic pain is affecting 38% of the global population.According to the "Report on the Development of Pain Medicine in China (2020)", the number of chronic pain patients in China exceeds 300 million, and is increasing at a rate of 10 to 20 million people per year.With the acceleration of modern life pace and aging process, the incidence of various pain-related diseases is also increasing rapidly.Fan Bifa, Director of the Pain Department at China-Japan Friendship Hospital, once stated: "The medical consultation rate for chronic pain patients in China is less than 60%."Many chronic pains that have become commonplace have not received enough attention."In the eyes of some people, pain is not a disease but a tolerable sensation. However, much pain caused by illnesses serves as a "dangerous signal" that, if not addressed promptly, can affect the treatment of the primary condition.In 2007, the pain management department was officially established in China. Over the past 16 years, the department's development has gradually become standardized, and the number of pain management doctors has been steadily increasing. However, overall, compared to the vast patient population of 300 million,In China, there are insufficient hospitals and doctors specializing in pain management, and there is also a lack of dedicated medical devices.Currently,New Cloud Medical has built up coverage in three major fields: minimally invasive surgery, neuromodulation, and transcutaneous electrical stimulation.The pain product pipeline, where several products have broken the technological monopoly of foreign enterprises.In the field of minimally invasive intervention:New Cloud Medical independently developedThe First in ChinaFor Lumbar Spinal CanalMinimally Invasive Surgical Instrument Kit NewMild for Lumbar Spinal Stenosis (LSS),Will Provide a Better Surgical Option for Ligamentum Flavum Hypertrophy-Type LSS.This minimally invasive surgery requires only a tiny incision to remove excess ligaments, treating LSS at its source. It also has safety characteristics similar to epidural steroid injections, allowing patients to move freely within 24 hours after the procedure. This not only shortens the recovery period but also reduces the financial burden on patients.Patients with lumbar spinal stenosis are widely distributed at the grassroots level.By performing surgeries through NewMild, the operational difficulty can be reduced, the learning curve for grassroots doctors shortened, and the treatment rate for grassroots patients improved.Founder of New Cloud Medical, Zhao YunMentioned that, in patients whoIf conditions permit, this minimally invasive surgical procedure for lumbar spinal stenosis is expected to be performed as day surgery, alleviating the problem of hospital bed shortages and reducing overall surgical costs.Performing Minimally Invasive Decompression Surgery for Lumbar Spinal Stenosis Using NewMildIn the field of neuromodulation:
New Cloud Medical LaunchesChina's First Closed-Loop Active Implantable Rechargeable Spinal Cord Stimulation System。In recent years, neuromodulation technologies represented by spinal cord stimulation (SCS) have shown excellent results in the treatment of chronic pain. International giants such as Abbott and Medtronic have also increased their R&D investment in SCS.The current mainstream spinal cord stimulation system is an open-loop stimulation system. During the surgery, effective stimulation parameters are selected based on the patient's paresthesia and pain relief level, and then the stimulation parameters are fixed. After a period of time post-surgery, it is necessary to adjust the stimulation amplitude via remote control to reduce the possibility of overstimulation or understimulation.But there is a risk of reduced treatment effectiveness.
New Cloud Medical independently developedClosed-loop active implantable and rechargeable spinal cord stimulation system based on evoked compound action potential (ECAP) technology.For each stimulus pulse, the ECAP can reflect the degree of sensory fiber excitation it induces, thereby altering the pain coverage area of SCS.
The pulse generator (IPG) uses ECAP as the feedback signal for stimulation and can automatically adjust stimulation parameters to keep the excitation level of sensory fibers in the spinal cord target area within an appropriate range.Achieve stable and effective analgesic effects.
Closed-loop Active Implantable Rechargeable Spinal Cord Stimulation System
This product is able to overcome the issue of low clinical effectiveness associated with traditional SCS systems and is expected to "disrupt" the existing market.Currently, New Cloud Medical's closed-loop active implantable rechargeable spinal cord stimulation system has completed animal experiments and is advancing into human clinical trials.In terms of pain management needs inside and outside the hospital:Based on the demand for pain management inside and outside the hospital, New Cloud Medical has established a digital pain management platform using artificial intelligence algorithms. Preoperatively, it can automatically select the appropriate electrode based on the patient's condition and precisely locate the electrode implantation position, providing accurate preoperative planning for clinical use; postoperatively, it can monitor the patient’s status in real time and record relevant data, helping doctors achieve remote monitoring and facilitating out-of-hospital management.
Preoperative Precision Planning for SCS Based on Artificial Intelligence
New Cloud Medical Technology Co., Ltd. (Abbreviation: New Cloud Medical) was founded in 2016. It is an innovative medical device company centered on pain management doctors and serving patients. The company's R&D center is located in Changping District, Beijing, and it has a 6000m² GMP-standard industrial production base in Jiangsu Province.
In addition to innovative products such as the minimally invasive surgical instrument kit for lumbar spinal stenosis (NewMild) and the closed-loop rechargeable active implantable spinal cord stimulation system (CalmStim), the companyWearable Intelligent Analgesic Device "Smart Cloud Patch"Has been approved for Class II medical device registration certificate,The medical consumables series has been mass-produced and exported to Europe and the United States. The migraine treatment device, minimally invasive surgical innovation instrument series, and neuromodulation product series are in the registration application phase.Based on leading technological innovation and product development capabilities, New Cloud Medical has successively received nearly 100 million yuan in investments from well-known VC institutions such as Zhonglu Capital, Legend Star, and Jinkex Junchuang, accelerating the product development and application process. Using technology innovation treatment methods to improve the quality of life for pain patients.As of the date of publication, the company's financing history is as follows:
As of the date of publication, the following is a partial list of the company's patent information:
Editor-in-Chief | Zhao Qing Reviewer | Yi He Typesetting | Miya
